SOTERA HEALTH COMPANY Increase (Decrease) in Inventories
SOTERA HEALTH COMPANY (SHC) reported Increase (Decrease) in Inventories of $4.12 million for the 6-month period ending 2026-06-30, per its 10-Q filed 2026-08-06.
Financial Statements › Cash Flow › Operating Activities
us-gaap:IncreaseDecreaseInInventories · last filed 2026-08-06
- SOTERA HEALTH COMPANY increase (decrease) in inventories for the quarter ending 2026-06-30 was $33.00K.
- SOTERA HEALTH COMPANY increase (decrease) in inventories for the quarter ending 2026-03-31 was $4.09M, a 65.47% decline year-over-year.
- SOTERA HEALTH COMPANY increase (decrease) in inventories for the quarter ending 2025-12-31 was $3.75M.
- SOTERA HEALTH COMPANY increase (decrease) in inventories for the quarter ending 2025-09-30 was -$9.04M.
- SOTERA HEALTH COMPANY increase (decrease) in inventories for fiscal 2025 was $2.38M, a 49.99% decline from fiscal 2024.
- SOTERA HEALTH COMPANY increase (decrease) in inventories for fiscal 2024 was $4.75M, a 52.34% decline from fiscal 2023.
- SOTERA HEALTH COMPANY increase (decrease) in inventories for fiscal 2023 was $9.97M.
- SOTERA HEALTH COMPANY increase (decrease) in inventories for fiscal 2022 was -$14.44M, a 171.33% decline from fiscal 2021.
| Period end | Increase (Decrease) in Inventories 3 month | Increase (Decrease) in Inventories 6 month | Increase (Decrease) in Inventories 9 month | Increase (Decrease) in Inventories 12 month |
|---|---|---|---|---|
| 2026-06-30 | $33.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2026-08-06 | $4.12M 10-Q · filed 2026-08-06 | $7.88M derived: sum of 3 quarters · filed 2026-08-06 | -$1.17M derived: sum of 4 quarters · filed 2026-08-06 |
| 2026-03-31 | $4.09M 10-Q · filed 2026-05-05 | $7.84M derived: sum of 2 quarters · filed 2026-05-05 | -$1.20M derived: sum of 3 quarters · filed 2026-05-05 | -$5.37M derived: sum of 4 quarters · filed 2026-08-06 |
| 2025-12-31 | $3.75M derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-24 | -$5.29M derived: sum of 2 quarters · filed 2026-02-24 | -$9.46M derived: sum of 3 quarters · filed 2026-08-06 | $2.38M 10-K · filed 2026-02-24 |
| 2025-09-30 | -$9.04M derived: 10-Q 9 month − 10-Q 6 month · filed 2025-11-04 | -$13.22M derived: sum of 2 quarters · filed 2026-08-06 | -$1.38M 10-Q · filed 2025-11-04 | -$2.85M derived: sum of 4 quarters · filed 2026-08-06 |
| 2025-06-30 | -$4.18M derived: 10-Q 6 month − 10-Q 3 month · filed 2026-08-06 | $7.66M 10-Q · filed 2026-08-06 | $6.19M derived: sum of 3 quarters · filed 2026-08-06 | $1.33M derived: sum of 4 quarters · filed 2026-08-06 |
| 2025-03-31 | $11.84M 10-Q · filed 2026-05-05 | $10.37M derived: sum of 2 quarters · filed 2026-05-05 | $5.51M derived: sum of 3 quarters · filed 2026-05-05 | $12.54M derived: sum of 4 quarters · filed 2026-05-05 |
| 2024-12-31 | -$1.47M derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-24 | -$6.33M derived: sum of 2 quarters · filed 2026-02-24 | $701.00K derived: sum of 3 quarters · filed 2026-02-24 | $4.75M 10-K · filed 2026-02-24 |
| 2024-09-30 | -$4.86M derived: 10-Q 9 month − 10-Q 6 month · filed 2025-11-04 | $2.17M derived: sum of 2 quarters · filed 2025-11-04 | $6.22M 10-Q · filed 2025-11-04 | $15.33M derived: sum of 4 quarters · filed 2026-02-24 |
| 2024-06-30 | $7.03M derived: 10-Q 6 month − 10-Q 3 month · filed 2025-08-08 | $11.08M 10-Q · filed 2025-08-08 | $20.19M derived: sum of 3 quarters · filed 2026-02-24 | $17.18M derived: sum of 4 quarters · filed 2026-02-24 |
| 2024-03-31 | $4.05M 10-Q · filed 2025-05-01 | $13.16M derived: sum of 2 quarters · filed 2026-02-24 | $10.15M derived: sum of 3 quarters · filed 2026-02-24 | $4.51M derived: sum of 4 quarters · filed 2026-02-24 |
| 2023-12-31 | $9.11M derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-24 | $6.09M derived: sum of 2 quarters · filed 2026-02-24 | $460.00K derived: sum of 3 quarters · filed 2026-02-24 | $9.97M 10-K · filed 2026-02-24 |
| 2023-09-30 | -$3.01M derived: 10-Q 9 month − 10-Q 6 month · filed 2024-11-05 | -$8.65M derived: sum of 2 quarters · filed 2024-11-05 | $866.00K 10-Q · filed 2024-11-05 | $321.00K derived: sum of 4 quarters · filed 2025-02-27 |
| 2023-06-30 | -$5.63M derived: 10-Q 6 month − 10-Q 3 month · filed 2024-08-05 | $3.88M 10-Q · filed 2024-08-05 | $3.33M derived: sum of 3 quarters · filed 2025-02-27 | $3.45M derived: sum of 4 quarters · filed 2025-02-27 |
| 2023-03-31 | $9.51M 10-Q · filed 2024-05-02 | $8.97M derived: sum of 2 quarters · filed 2025-02-27 | $9.08M derived: sum of 3 quarters · filed 2025-02-27 | $4.39M derived: sum of 4 quarters · filed 2025-02-27 |
| 2022-12-31 | -$545.00K derived: 10-K 12 month − 10-Q 9 month · filed 2025-02-27 | -$429.00K derived: sum of 2 quarters · filed 2025-02-27 | -$5.12M derived: sum of 3 quarters · filed 2025-02-27 | -$14.44M 10-K · filed 2025-02-27 |
| 2022-09-30 | $116.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2023-11-01 | -$4.57M derived: sum of 2 quarters · filed 2023-11-01 | -$13.90M 10-Q · filed 2023-11-01 | $2.92M derived: sum of 4 quarters · filed 2024-02-27 |
| 2022-06-30 | -$4.69M derived: 10-Q 6 month − 10-Q 3 month · filed 2023-08-03 | -$14.01M 10-Q · filed 2023-08-03 | $2.80M derived: sum of 3 quarters · filed 2024-02-27 | $5.46M derived: sum of 4 quarters · filed 2024-02-27 |
| 2022-03-31 | -$9.32M 10-Q · filed 2023-05-03 | $7.49M derived: sum of 2 quarters · filed 2024-02-27 | $10.15M derived: sum of 3 quarters · filed 2024-02-27 | $12.02M derived: sum of 4 quarters · filed 2024-02-27 |
| 2021-12-31 | $16.82M derived: 10-K 12 month − 10-Q 9 month · filed 2024-02-27 | $19.48M derived: sum of 2 quarters · filed 2024-02-27 | $21.34M derived: sum of 3 quarters · filed 2024-02-27 | $20.25M 10-K · filed 2024-02-27 |
| 2021-09-30 | $2.66M derived: 10-Q 9 month − 10-Q 6 month · filed 2022-11-02 | $4.53M derived: sum of 2 quarters · filed 2022-11-02 | $3.43M 10-Q · filed 2022-11-02 | $6.82M derived: sum of 4 quarters · filed 2023-02-28 |
| 2021-06-30 | $1.87M derived: 10-Q 6 month − 10-Q 3 month · filed 2022-08-04 | $770.00K 10-Q · filed 2022-08-04 | $4.16M derived: sum of 3 quarters · filed 2023-02-28 | $2.35M derived: sum of 4 quarters · filed 2023-02-28 |
| 2021-03-31 | -$1.10M 10-Q · filed 2022-05-05 | $2.29M derived: sum of 2 quarters · filed 2023-02-28 | $476.00K derived: sum of 3 quarters · filed 2023-02-28 | -$6.44M derived: sum of 4 quarters · filed 2023-02-28 |
| 2020-12-31 | $3.39M derived: 10-K 12 month − 10-Q 9 month · filed 2023-02-28 | $1.57M derived: sum of 2 quarters · filed 2023-02-28 | -$5.34M derived: sum of 3 quarters · filed 2023-02-28 | -$3.78M 10-K · filed 2023-02-28 |
| 2020-09-30 | -$1.82M derived: 10-Q 9 month − 10-Q 6 month · filed 2021-11-10 | -$8.73M derived: sum of 2 quarters · filed 2021-11-10 | -$7.17M 10-Q · filed 2021-11-10 | |
| 2020-06-30 | -$6.91M derived: 10-Q 6 month − 10-Q 3 month · filed 2021-08-12 | -$5.36M 10-Q · filed 2021-08-12 | ||
| 2020-03-31 | $1.55M 10-Q · filed 2021-05-13 | |||
| 2019-12-31 | $282.00K 10-K · filed 2022-03-01 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Progyny, Inc. (PGNY) | United States | $1.994B | 28.37 |
| agilon health, inc. (AGL) | United States | $1.272B | -7.76 |
| VIEMED HEALTHCARE, INC. (VMD) | United States | $0.336B | 29.92 |
| Park Dental Partners, Inc. (PARK) | United States | $0.094B | |
| BioRestorative Therapies, Inc. (BRTX) | United States | $0.064B | |
| CRYO CELL INTERNATIONAL INC (CCEL) | United States | $0.033B | -11.02 |
| MANGOCEUTICALS, INC. (MGRX) | United States | $0.010B | -0.43 |
| DAVITA INC. (DVA) | United States | $11.147B | 16.80 |